drugset / Trial / NCT02143856
Oral Bioavailability of Solid Formulation of GLPG1205 With and Without Food
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of the study is to evaluate the amount of compound present in the blood (relative bioavailability) after a single oral administration of GLPG1205 given as a capsule formulation in fasted versus fed conditions in male healthy subjects. Also, the safety and tolerability of a single oral dose of GLPG1205 given as a capsule formulation under fasted and fed conditions will be assessed.
Timeline
- Start
- 2014-05
- Primary completion
- 2014-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GLPG1205 | Small molecule | 100 mg | Oral |
Indications
No indication recorded.